Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie A O'Brien

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Molecular Pharmacology|July 28, 2010
The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric siteMarlene A Jacobson, Constantine Kreatsoulas, Danette M Pascarella, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Modulation of inhibitory transmission in the rat globus pallidus by activation of mGluR4Michael J Marino, Ornella Valenti, Julie A O'Brien, et al.
Annals of Surgical Oncology|August 13, 2015
Breast-Conserving Surgery in Bilateral Breast CancerJulie A O'Brien, Alice Ho, G Paul Wright, et al.
European Journal of Pharmacology|August 15, 2002
A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptorsWei Lemaire, Julie A O'Brien, Maryann Burno, et al.
Nuclear Medicine and Biology|March 22, 2008
A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studiesZhizhen Zeng, Julie A O'Brien, Wei Lemaire, et al.
Neuropharmacology|November 30, 2010
Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administrationSophie Parmentier-Batteur, Julie A O'Brien, Scott Doran, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2003
Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatmentMichael J Marino, David L Williams, Julie A O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2006
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamidesZhijian Zhao, Julie A O'Brien, Wei Lemaire, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2020
Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal modelsYouheng Shu, Tracy L Diamond, James C Hershey, et al.
Molecular Pharmacology|August 16, 2003
A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5Julie A O'Brien, Wei Lemaire, Tsing-Bau Chen, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Molecular Pharmacology|July 28, 2010
The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric siteMarlene A Jacobson, Constantine Kreatsoulas, Danette M Pascarella, et al.
Annals of the New York Academy of Sciences|December 20, 2003
Modulation of inhibitory transmission in the rat globus pallidus by activation of mGluR4Michael J Marino, Ornella Valenti, Julie A O'Brien, et al.
Annals of Surgical Oncology|August 13, 2015
Breast-Conserving Surgery in Bilateral Breast CancerJulie A O'Brien, Alice Ho, G Paul Wright, et al.
European Journal of Pharmacology|August 15, 2002
A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptorsWei Lemaire, Julie A O'Brien, Maryann Burno, et al.
Nuclear Medicine and Biology|March 22, 2008
A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studiesZhizhen Zeng, Julie A O'Brien, Wei Lemaire, et al.
Neuropharmacology|November 30, 2010
Differential effects of the mGluR5 positive allosteric modulator CDPPB in the cortex and striatum following repeated administrationSophie Parmentier-Batteur, Julie A O'Brien, Scott Doran, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2003
Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson's disease treatmentMichael J Marino, David L Williams, Julie A O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2006
Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamidesZhijian Zhao, Julie A O'Brien, Wei Lemaire, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2020
Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal modelsYouheng Shu, Tracy L Diamond, James C Hershey, et al.
Molecular Pharmacology|August 16, 2003
A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5Julie A O'Brien, Wei Lemaire, Tsing-Bau Chen, et al.
Pageof 3